Data Bridge Market Report present new report “APAC POCT Market" is expected to reach USD 4.66 billion by 2024 from USD 2.31 billion in 2016, at a CAGR of 9.2% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
- Advertising -
APAC Point-of-care Testing (POCT) Market By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits, & Others),By Prescription Mode (Prescription Based Testing & Over-The-Counter Testing),By Distribution Channel (Direct Tenders & Retail),By End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, & Research Laboratory), By Country (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines and Rest of APAC) – Trends and Forecast to 2024
- Rising cost of POCT devices and low reimbursement scenario are the factors which may hinder the growth of this market.
- Many companies are making continuous efforts and advances to make products more relevant, along with propelled innovations with reduced sample volume or less blood on portable devices.
- Scope for unmet medical needs as well as emerging POCT device will drive the market in future.
Ask for Free Sample Report Visit @ databridgemarketresearch.com/reque…sting-poct-market
The APAC POCT Device Market is segmented on the basis of product type, prescription mode, distribution channel, end user, and geography. The APAC POCT device market is segmented into twelve product types, such as blood glucose testing kits, cardio metabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.
In 2017, the blood glucose testing kits segment is expected to dominate the market with a share of 24.2% and is expected to continue this trend till 2024.
Cardiometabolic monitoring kits are further segmented into cardiac markers, blood gas/electrolytes testing kits, HbA1c testing kits, and lipids testing.
- Advertising -
Also, infectious disease testing kits are further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections, and respiratory infections testing kit. Cholesterol testing kits are further divided into prothrombin time testing kits and activated clotting time testing kit.
On the basis of prescription mode, the APAC point-of-care testing market is segmented into prescription based testing and over-the-counter (OTC) testing. The OTC testing is projected to witness higher growth rate of 9.7% during the forecast period to reach a value of USD 1.68 billion by 2024.
On the basis of distribution channel, the APAC point-of-care testing market is segmented into direct tenders and retail. In 2017, the direct tender market is expected to dominate the market with a value of USD 1.67 billion.
On the basis of end users, the APAC point-of-care testing market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory. In 2017, the hospital segment is expected to dominate with the market share of 33.2% and is expected to continue this trend till 2024.
Hoffmann La Roche Diagnostics Limited is dominating the APAC POCT device market major players followed by
- Alere Inc.
- Siemens AG
- Dickinson and Company
- Johnson & Johnson Services Inc.
- PTS Diagnostics
- Among others
Read more about the APAC Point-of-care Testing (POCT) Market Visit@ databridgemarketresearch.com/repor…ting-poct-market/
Table of Contents:
1.1. Objectives Of The Study
1.2. Market Definition
1.3. Overview Of Apac Point-Of-Care Testing Market
- Market Segmentation
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
- Market Overview
- Executive Summary
- Premium Insights
- Apac Point-Of-Care Testing Market: Regulatory Scenario
6.4. India (Cdsco)
6.5. Japan (Mhlw)
- Apac Point-Of-Care Testing Market: Reimbursement Scenario
- Apac Point-Of-Care Testing Market, By Product Type
8.2. Cardiometabolic Monitoring Kits
8.3. Infectious Disease Testing Kits
8.4. Cholesterol Testing Kits
8.5. Blood Glucose Testing Kits
- Apac Point-Of-Care Testing Market, By Distribution Channel
- Apac Point-Of-Care Testing Market, By End User
10.2. Apac Poct Market: Hospitals
10.3. Apac Poct Market: Clinics
- Apac Point-Of-Care Testing Market, By Prescription Mode
11.2. Apac Poct Market: Prescription Based Testing Kits
11.3. Apac Poct Market: Over The Counter Based Testing Kits
- Apac Point-Of-Care Testing Market, By Geography
12.1. Apac Point-Of-Care Testing Market
12.2. Company Share Analysis: Apac
- Company Profiles
13.1. Johnson And Johnson Services, Inc.
13.2. Becton, Dickinson And Company
13.4. F. Hoffmann-La Roche Ltd
13.5. Siemens Ag
Browse Detailed TOC, Tables and Figures @ databridgemarketresearch.com/toc/?…ting-poct-market
Category: Market Research Publishers and RetailersCompany about: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: